# DENTSPLY (XRAY) — Analyst Forecast

XRAY · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/xray/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Hold | 4 | 13 | 2 | 19 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $10.00 | $10.75 | $12.00 | 4 |

Last price $8.83 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 14, 2026 | Leerink Partners | Maintained | Market Perform | $10.00 |
| Oct 9, 2026 | Piper Sandler | Maintained | Neutral | $12.00 |
| Sep 17, 2026 | BMO Capital | Maintained | Market Perform | $10.00 |
| Aug 24, 2026 | Barclays | Maintained | Underweight | $11.00 |
| Jul 29, 2026 | Piper Sandler | Maintained | Neutral | $14.00 |
| Jul 9, 2026 | BMO Capital | Initiated Coverage | Market Perform | $12.00 |
| Jun 4, 2026 | Barclays | Maintained | Underweight | $9.00 |
| May 7, 2026 | UBS | Maintained | Buy | $17.00 |
| May 6, 2026 | Mizuho | Maintained | Neutral | $14.00 |
| Apr 15, 2026 | Citigroup | Initiated Coverage | Sell | $10.00 |
| Mar 2, 2026 | Barrington Research | Maintained | Outperform | $17.00 |
| Mar 2, 2026 | Mizuho | Maintained | Neutral | $16.00 |
| Feb 27, 2026 | Evercore ISI Group | Maintained | In-Line | $15.00 |
| Feb 27, 2026 | Baird | Maintained | Neutral | $14.00 |
| Feb 27, 2026 | Wells Fargo | Maintained | Equal-Weight | $13.00 |
| Feb 19, 2026 | B of A Securities | Upgraded | Neutral → Buy | $17.00 |
| Feb 3, 2026 | UBS | Maintained | Buy | $16.00 |
| Jan 20, 2026 | Mizuho | Maintained | Neutral | $14.00 |
| Jan 5, 2026 | Barrington Research | Maintained | Outperform | $14.00 |
| Dec 16, 2025 | Baird | Maintained | Neutral | $12.00 |

## Frequently Asked Questions

### What is the price target for XRAY stock?

The average 12-month analyst price target for DENTSPLY (XRAY) is $10.75, with a high estimate of $12.00 and a low of $10.00, across 4 analysts.

### Is XRAY a buy, sell, or hold?

Analysts covering DENTSPLY currently average a Hold rating: 4 buy, 13 hold and 2 sell, from 19 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for XRAY?

The average price target of $10.75 implies 21.74% upside from the last price of $8.83.

### What is the latest analyst rating on XRAY?

On Oct 14, 2026, Leerink Partners maintained DENTSPLY at Market Perform with a price target of $10.00.

## Similar Stocks

- [COO](https://www.lighthorse.io/tickers/coo) — The Cooper Companies, Inc.  - Common Stock
- [MMSI](https://www.lighthorse.io/tickers/mmsi) — Merit Medical Systems, Inc. - Common Stock
- [NVST](https://www.lighthorse.io/tickers/nvst) — Envista Holdings Corporation Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).